Monday, October 10, 2011

Free Webinar: Blood Safety Study Results - Fri., Oct. 14.

Free Webinar: Blood Safety Study Results
>
> Webinar: Fri., Oct. 14.
> Join us on Oct. 14, 2011 to hear from leaders of the Blood XMRV Scientific Research Working Group about the results of their study reported last month in Science. Free registration: https://www1.gotomeeting.com/register/606452768
>
> Background:
> A report in Oct. 2009 linked CFS to the retrovirus xenotropic murine leukemia virus-related virus (XMRV -- http://www.research1st.com/2011/09/13/the-x-factor/). In late 2009 the Blood XMRV Scientific Research Working Group was formed by the U.S. Department of Health and Human Services to design and carry out a study to determine whether XMRV posed a threat to blood safety. The multiphase, multicenter study has been supported by the National Heart, Lung and Blood Institute and coordinated by the Department of Health and Human Services Blood XMRV Scientific Research Working Group.
>
> Results from Phase I of the study were reported in July 2010 at a meeting of the Food and Drug Administration's Blood Products Advisory Committee (BPAC). Phase II results were presented at a BPAC meeting in December 2010 and in a webinar (http://www.youtube.com/watch?v=0HynlkG0cVc). Phase III results were published on Sept. 22, 2011 in Science (http://www.research1st.com/2011/09/22/study-summaries/) and presented at the IACFS/ME conference in Ottawa on Sept. 23, 2011. None of the 19 assays used by nine participating labs was able to distinguish previously XMRV/MLV-positive CFS cases from healthy blood donors or pedigreed negatives on the basis of results for XMRV or the larger family of murine leukemia viruses for which they tested.
>
> Study leaders will repeat the Ottawa presentation via a webinar with open registration, thus enabling a larger number of stakeholders to hear directly about the study design, results and conclusions. Drs. Michael Busch, Graham Simmons and Steven Kleinman will discuss consequences for blood safety and the understanding of these agents' role in CFS. Written questions can be submitted at the time of registration or by participants during the webinar.
>
> Webinar Details:
> Date: October 14, 2011
> Time: 4:00 PM - 5:00 PM (Eastern time)
> Speakers:
> Graham Simmons, PhD of Blood Systems Research Institute
>
> Michael Busch, MD, PhD of Blood Systems Research Institute
>
> Steven Kleinman, BSc, MD of University of British Columbia
>
> Free registration: https://www1.gotomeeting.com/register/606452768
>
> ~~~~~~~~~~~~~~~~~~~
> Related Resources
>
> For more information about the Sept. 22, 2011 report in Science of the Phase III results, please visit http://www.research1st.com/2011/09/22/study-summaries/
>
> For more information about XMRV, please visit http://www.research1st.com/2011/09/13/the-x-factor/
>
> For a list of XMRV-related articles and publications, please visit http://www.cfids.org/xmrv/resource-listing.asp
>
> For information about blood donation by individuals with CFS, please visit http://www.cfids.org/blood.asp
>
> For the recording of the Phase ll results webinar, please visit http://www.youtube.com/watch?v=0HynlkG0cVc

No comments: